Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
GSL | Insolvent trading claim and related entities | 26/09/24 | 4 | 5.8K | |||
|
|||||||
GSL | Capital Raise for NEW Greatcell | 26/09/24 | 13 | 26K | |||
|
|||||||
GSL | "Time" | 17/02/21 | 9 | 14K | |||
|
|||||||
GSL | Greatcell Rescue | 14/10/19 | 87 | 130K | |||
|
|||||||
GSL | Ann: Removal from Official List - Annual Listing Fees | 29/08/19 | 0 | 3.0K | |||
|
|||||||
GSL | Ann: Suspension from Official Quotation - Annual Listing Fee | 22/08/19 | 0 | 2.6K | |||
|
|||||||
GSL | The reality | 15/07/19 | 4 | 6.5K | |||
|
|||||||
GSL | Article | 28/04/19 | 14 | 15K | |||
|
See All Discussions